Posterior circulation strokes account for up to 30% of all ischemic strokes, and atherosclerotic occlusive disease of the vertebrobasilar (VB) system is an important etiology, responsible for approximately one-third of the cases.
1,2 Symptomatic atherosclerotic VB occlusive disease is associated with a high risk of recurrent stroke despite medical therapy, occurring in 10% to 15% of the patients within 2 years.
3-8 Despite this prevalence and potentially devastating prognosis, the posterior circulation has largely been overlooked compared with the extensive emphasis on carotid artery territory stroke. This discrepancy may be related, at least in part, to the greater challenges of surgical interventions for the VB system compared with the carotid system.
9,10 However, advances in endovascular treatment options for VB occlusive disease in recent years have kindled interest in interventional therapies. Endovascular angioplasty and stenting in the posterior circulation are now technically feasible but still carry a significant periprocedural risk
11-13; therefore, such therapies are likely to benefit only selected patients at highest risk of recurrent ischemia.